2-216678182-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000599.4(IGFBP5):c.617G>A(p.Ser206Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000094 in 1,595,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000599.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000289 AC: 7AN: 242398 AF XY: 0.0000305 show subpopulations
GnomAD4 exome AF: 0.00000970 AC: 14AN: 1443774Hom.: 0 Cov.: 30 AF XY: 0.00000836 AC XY: 6AN XY: 717594 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.617G>A (p.S206N) alteration is located in exon 3 (coding exon 3) of the IGFBP5 gene. This alteration results from a G to A substitution at nucleotide position 617, causing the serine (S) at amino acid position 206 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at